I think what you’re missing is the math done by blafarm and my point. Your theory or idea doesn’t quite line up with the 100million in revenue projected by Nader, it is likely there will be remaining vials, basically answering blafarms question about price per vial. It is highly unlikely cytodyn will sell them all at $160 each when they can get tens of thousands per vial for other indications